OMERS ADMINISTRATION Corp Has $5.59 Million Position in Corteva, Inc. $CTVA

OMERS ADMINISTRATION Corp lifted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 18.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 66,744 shares of the company’s stock after purchasing an additional 10,573 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Corteva were worth $5,587,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Corteva by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after buying an additional 317,538 shares during the last quarter. State Street Corp increased its position in Corteva by 3.7% in the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Corteva by 4.3% in the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares during the last quarter. Harris Associates L P raised its stake in shares of Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after acquiring an additional 10,675,052 shares during the last quarter. Finally, Northern Trust Corp lifted its position in shares of Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after purchasing an additional 562,550 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Down 0.0%

Shares of NYSE:CTVA opened at $89.23 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock has a market cap of $59.68 billion, a price-to-earnings ratio of 52.49, a P/E/G ratio of 2.70 and a beta of 0.56. The company has a 50 day moving average of $81.39 and a 200-day moving average of $78.99. Corteva, Inc. has a one year low of $60.53 and a one year high of $89.39.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the business posted $1.13 earnings per share. Corteva’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.76 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is 42.35%.

Key Headlines Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Oppenheimer raised its price target on Corteva to $95 from $89 and kept an “outperform” rating, signaling confidence in further upside for the stock.
• Positive Sentiment: Zacks upgraded Corteva to Rank #2 (Buy), citing improving earnings prospects ahead of the company’s upcoming results.
• Positive Sentiment: Analysts expect Q2 earnings growth as premium seed demand, new products, and productivity gains help offset pricing and inflation pressure. Corteva Set to Report Q2 Earnings: What Investors Should Expect
• Neutral Sentiment: Corteva declared a quarterly dividend of $0.18 per share, payable September 15 to shareholders of record on September 1, which supports the stock’s income profile but is not a major growth catalyst. Corteva Declares Quarterly Dividend
• Neutral Sentiment: The company is set to report Q2 earnings soon, and investors are awaiting confirmation that demand and operating efficiency trends are holding up. Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday

Analyst Upgrades and Downgrades

Several analysts have recently commented on CTVA shares. Citigroup increased their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Royal Bank Of Canada boosted their price objective on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 21st. The Goldman Sachs Group increased their price objective on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. BNP Paribas Exane lifted their target price on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Finally, Morgan Stanley lifted their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.